
Andrea K. Mccollum
Examiner (ID: 11971, Phone: (571)272-4002 , Office: P/1646 )
| Most Active Art Unit | 1646 |
| Art Unit(s) | 1674, 1646 |
| Total Applications | 733 |
| Issued Applications | 360 |
| Pending Applications | 111 |
| Abandoned Applications | 301 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15206399
[patent_doc_number] => 20190365886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => VACCINE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/244358
[patent_app_country] => US
[patent_app_date] => 2019-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25566
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16244358
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/244358 | VACCINE COMPOSITIONS | Jan 9, 2019 | Abandoned |
Array
(
[id] => 15178257
[patent_doc_number] => 20190359720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => ST2 ANTIGEN BINDING PROTEINS
[patent_app_type] => utility
[patent_app_number] => 16/242278
[patent_app_country] => US
[patent_app_date] => 2019-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52509
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16242278
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/242278 | ST2 antigen binding proteins | Jan 7, 2019 | Issued |
Array
(
[id] => 15254127
[patent_doc_number] => 20190375797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => METHODS AND THERAPEUTICS COMPRISING LIGAND-TARGETED ELPs
[patent_app_type] => utility
[patent_app_number] => 16/230698
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14204
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16230698
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/230698 | Methods and therapeutics comprising ligand-targeted ELPs | Dec 20, 2018 | Issued |
Array
(
[id] => 14099235
[patent_doc_number] => 20190091293
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => SLEEP APNEA TREATMENT
[patent_app_type] => utility
[patent_app_number] => 16/202730
[patent_app_country] => US
[patent_app_date] => 2018-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11958
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16202730
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/202730 | Sleep apnea treatment | Nov 27, 2018 | Issued |
Array
(
[id] => 14306037
[patent_doc_number] => 20190142722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => METHODS AND COMPOSITIONS FOR PROMOTING OR INDUCING HAIR GROWTH
[patent_app_type] => utility
[patent_app_number] => 16/186186
[patent_app_country] => US
[patent_app_date] => 2018-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23280
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16186186
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/186186 | METHODS AND COMPOSITIONS FOR PROMOTING OR INDUCING HAIR GROWTH | Nov 8, 2018 | Abandoned |
Array
(
[id] => 14099319
[patent_doc_number] => 20190091335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => ANTIBODY FORMULATIONS CONTAINING AMINO ACIDS
[patent_app_type] => utility
[patent_app_number] => 16/174004
[patent_app_country] => US
[patent_app_date] => 2018-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30054
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16174004
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/174004 | ANTIBODY FORMULATIONS CONTAINING AMINO ACIDS | Oct 28, 2018 | Abandoned |
Array
(
[id] => 14159189
[patent_doc_number] => 20190106697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-11
[patent_title] => Inhibition Of Lactate Transporters For Use In The Treatment Of Inflammatory Diseases
[patent_app_type] => utility
[patent_app_number] => 16/161517
[patent_app_country] => US
[patent_app_date] => 2018-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9536
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16161517
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/161517 | Inhibition Of Lactate Transporters For Use In The Treatment Of Inflammatory Diseases | Oct 15, 2018 | Abandoned |
Array
(
[id] => 14182745
[patent_doc_number] => 20190111077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => LHRH-Platinum Conjugates for Treating Reproductive Cancers
[patent_app_type] => utility
[patent_app_number] => 16/159232
[patent_app_country] => US
[patent_app_date] => 2018-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5357
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16159232
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/159232 | LHRH-platinum conjugates for treating reproductive cancers | Oct 11, 2018 | Issued |
Array
(
[id] => 16206572
[patent_doc_number] => 20200239562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => ANTI-IL-33 THERAPY FOR ATOPIC DERMATITIS
[patent_app_type] => utility
[patent_app_number] => 16/755002
[patent_app_country] => US
[patent_app_date] => 2018-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11106
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16755002
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/755002 | ANTI-IL-33 THERAPY FOR ATOPIC DERMATITIS | Oct 8, 2018 | Abandoned |
Array
(
[id] => 13867657
[patent_doc_number] => 20190030169
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => STABILIZING AGENT FOR PHARMACEUTICAL PROTEINS
[patent_app_type] => utility
[patent_app_number] => 16/145040
[patent_app_country] => US
[patent_app_date] => 2018-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4848
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16145040
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/145040 | STABILIZING AGENT FOR PHARMACEUTICAL PROTEINS | Sep 26, 2018 | Abandoned |
Array
(
[id] => 13790879
[patent_doc_number] => 20190008978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-10
[patent_title] => CONJUGATES OF AN IL-2 MOIETY AND A POLYMER
[patent_app_type] => utility
[patent_app_number] => 16/139957
[patent_app_country] => US
[patent_app_date] => 2018-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21193
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16139957
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/139957 | Method of refolding an interleukin-2 (IL-2) protein | Sep 23, 2018 | Issued |
Array
(
[id] => 13837403
[patent_doc_number] => 20190022186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-24
[patent_title] => COMPOSITIONS AND METHODS TO MITIGATE OR PREVENT AN IMMUNE RESPONSE TO AN IMMUNOGENIC THERAPEUTIC MOLECULE IN NON-HUMAN PRIMATES
[patent_app_type] => utility
[patent_app_number] => 16/138787
[patent_app_country] => US
[patent_app_date] => 2018-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12937
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16138787
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/138787 | Compositions and methods to mitigate or prevent an immune response to an immunogenic therapeutic molecule in non-human primates | Sep 20, 2018 | Issued |
Array
(
[id] => 13790805
[patent_doc_number] => 20190008941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-10
[patent_title] => COMBINED THERAPY AND PROPHYLAXIS FOR GENITAL TRACT INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 16/138526
[patent_app_country] => US
[patent_app_date] => 2018-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16755
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16138526
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/138526 | COMBINED THERAPY AND PROPHYLAXIS FOR GENITAL TRACT INFECTIONS | Sep 20, 2018 | Abandoned |
Array
(
[id] => 13986543
[patent_doc_number] => 20190062429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => Targeting tissue factor to activated platelets
[patent_app_type] => utility
[patent_app_number] => 16/130339
[patent_app_country] => US
[patent_app_date] => 2018-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42688
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16130339
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/130339 | Targeting tissue factor to activated platelets | Sep 12, 2018 | Abandoned |
Array
(
[id] => 16254817
[patent_doc_number] => 20200264191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => METHODS AND KITS FOR DIAGNOSIS OF FAMILIAL MEDITERRANEAN FEVER
[patent_app_type] => utility
[patent_app_number] => 16/645191
[patent_app_country] => US
[patent_app_date] => 2018-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11169
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16645191
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/645191 | METHODS AND KITS FOR DIAGNOSIS OF FAMILIAL MEDITERRANEAN FEVER | Sep 5, 2018 | Abandoned |
Array
(
[id] => 14016537
[patent_doc_number] => 20190070262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-07
[patent_title] => INTERLEUKIN-18 VARIANTS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/123063
[patent_app_country] => US
[patent_app_date] => 2018-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57645
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16123063
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/123063 | INTERLEUKIN-18 VARIANTS AND METHODS OF USE | Sep 5, 2018 | Abandoned |
Array
(
[id] => 17074908
[patent_doc_number] => 11111293
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-07
[patent_title] => IL-18 binding molecules
[patent_app_type] => utility
[patent_app_number] => 16/111659
[patent_app_country] => US
[patent_app_date] => 2018-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 39
[patent_no_of_words] => 48750
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16111659
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/111659 | IL-18 binding molecules | Aug 23, 2018 | Issued |
Array
(
[id] => 16438377
[patent_doc_number] => 20200355703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => DETECTION OF INSULIN IN SALIVA AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/640378
[patent_app_country] => US
[patent_app_date] => 2018-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17834
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16640378
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/640378 | DETECTION OF INSULIN IN SALIVA AND METHODS OF USE THEREOF | Aug 19, 2018 | Abandoned |
Array
(
[id] => 14102343
[patent_doc_number] => 20190092847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => TGF-ss1 SPECIFIC ANTIBODIES AND METHODS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/046025
[patent_app_country] => US
[patent_app_date] => 2018-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24313
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16046025
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/046025 | TGF-ss1 specific antibodies and methods and uses thereof | Jul 25, 2018 | Issued |
Array
(
[id] => 13533727
[patent_doc_number] => 20180318406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-08
[patent_title] => KEXIN-DERIVED VACCINES TO PREVENT OR TREAT FUNGAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 16/035319
[patent_app_country] => US
[patent_app_date] => 2018-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20841
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16035319
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/035319 | KEXIN-DERIVED VACCINES TO PREVENT OR TREAT FUNGAL INFECTIONS | Jul 12, 2018 | Abandoned |